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Modulation of Sleep Quality and Autonomic
Functioning by Symptoms of Depression
in Women with Irritable Bowel Syndrome
JENNIFER J. T. ROBERT, PhD,*§ WILLIAM C. ORR, PhD,† and SIGRID ELSENBRUCH, PhD‡
The objective of this study was to determine how depressive symptoms affect autonomic activity
during sleep, objective and subjective sleep, and gastrointestinal symptom severity in women with
irritable bowel syndrome (IBS). Seventy women who met the Rome II criteria for IBS and 21
healthy volunteers participated. All participants were recruited from the surrounding community. IBS
patients were stratified into two groups based on their Beck Depression Inventory II score and 44 IBS
patients with depressive symptoms (IBS+DS) were compared to 26 IBS patients without depressive
symptoms (IBS−DS). Autonomic activity was measured by heart rate variability (HRV) analysis.
Fifteen-minute segments were selected from a baseline presleep period, stage 2, slow-wave sleep,
and rapid-eye movement sleep for heart rate variability spectral analysis. Subjective sleep quality
was assessed by the Pittsburg Sleep Quality Index (PSQI) and gastrointestinal symptom severity was
assessed by an 18-item questionnaire. The IBS+DS group reported significantly (P < 0.01) more
sleep complaints, measured by the PSQI, than the IBS−DS group and healthy controls. The IBS+DS
group took significantly (P < 0.05) longer to enter their first rapid-eye movement period than healthy
controls. The IBS+DS group reported significantly (P = 0.01) increased gastrointestinal symptom
severity compared to the IBS−DS group. There were no significant group differences in autonomic
activity during the baseline presleep period or sleep stages. The results demonstrated that IBS patients
with significant depressive symptoms had increased gastrointestinal symptom severity, increased
sleep complaints, and alterations in sleep architecture compared to healthy controls and IBS patients
without significant depressive symptoms.
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In recent years, a shift in the conception of irritable bowel
syndrome (IBS) has occurred from a disease-based re-
ductionistic model to a biopsychosocial model of illness
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(1, 2). The biopsychosocial model integrates psychoso-
cial factors such as stress and psychological state with the
physiological mechanisms thought to be involved in IBS
(1, 3). According to the model, psychosocial factors influ-
ence IBS symptoms, clinical outcome, and treatment (4).
A large proportion of IBS patients also meets the criteria
for a psychiatric disorder, mostly anxiety and/or depres-
sion, and varies according to whether the sample was from
a tertiary center or a community sample.
Sleep disturbance is a common symptom of depres-
sion and IBS. Research from our group, as well as others,
has demonstrated that women with IBS report more sleep
disturbances than healthy controls (9–14). Elsenbruch
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et al. investigated objective polysomnographic sleep mea-
sures to determine if the sleep complaints were accompa-
nied by changes in sleep architecture (9, 10). They found
that the sleep complaints were not mirrored by objective
measures; women with IBS had sleep architecture sim-
ilar to that of healthy controls. Moreover, these results
were confirmed in a subsequent investigation by the same
group (14). Elsenbruch and colleagues also investigated
the role of psychological disturbances on the mispercep-
tion of sleep in women with IBS (10). Because the pri-
mary objective of the previous investigations was to de-
termine the relationship of sleep complaints to objective
PSG measures, individuals with moderate to severe de-
pression, as measured by the Beck Depression Inventory
(BDI-II), were excluded. Despite the exclusion of those
individuals, IBS patients had increased psychological dis-
turbances with elevated depression scores. Results indi-
cated that the severity of psychological disturbance was
significantly correlated with subjective sleep complaints
(10). Thus, it appeared that psychological disturbances in
IBS patients contribute to self-reported sleep complaints.
The difference in sleep between IBS patients with concur-
rent depressive symptoms and patients without depressive
symptoms has not been investigated.
Autonomic abnormalities have been detected in both
IBS and depression (13–19). Orr and colleagues have con-
ducted a series of investigations of cardiac autonomic reg-
ulation during sleep in IBS patients (13, 14). They deter-
mined that IBS is associated with sympathetic dominance
during rapid-eye movement (REM) sleep in a group of IBS
patients (20% constipation-predominant, 80% alternating
constipation/diarrhea). In a subsequent study, women with
IBS who did not have dyspeptic symptoms were found to
have elevated sympathetic dominance during REM sleep
compared to women with IBS with dyspeptic symptoms
and controls (14). The increase in sympathetic dominance
in these studies was attributed to vagal withdrawal. A
seminal study was conducted by Iovino et al. demonstrat-
ing that the autonomic nervous system can modulate vis-
ceral perception in healthy controls (15). They induced
sympathetic activation via lower body negative pressure
and found that responses to duodenal stimulation were
sensitized.
Decreased heart rate variability (HRV) and increased
sympathetic dominance during daytime or averaged 24-hr
recordings have been found in persons with major de-
pression compared to nondepressed controls (16, 17). A
similar study to the present was conducted by Jarrett
et al., examining HRV across 24-hr periods in women
with IBS who had anxiety and depressive disorders (18).
They demonstrated lower vagal tone across 24-hr periods
in women with IBS who had clinically diagnosed depres-
sion compared to a group of women with IBS who did not
have affective disorders. Another study reported higher
heart rates during sleep in depressed patients compared
to controls, but HRV was not utilized to determine auto-
nomic activity (19). To date, there has not been an investi-
gation of HRV during sleep stages utilizing polysomnog-
raphy (PSG) in individuals with IBS and concurrent
depression.
The primary hypothesis was to determine if depressive
symptoms in women with IBS were associated with sym-
pathetic dominance during REM sleep previously found
in women with IBS. If the results confirm the hypothesis,
then depression may be a significant factor mediating au-
tonomic dysfunction in women with IBS. The secondary
goal was to determine how significant depressive symp-
toms affect objective and subjective sleep and gastroin-
testinal symptom severity in women with IBS.
MATERIALS AND METHODS
Recruitment and Screening of Participants
The participants were recruited from the surrounding commu-
nity through public advertisement. Each participant underwent
a screening process that involved a structured telephone screen-
ing and a personal interview. Women with symptoms of IBS
described their gastrointestinal symptoms during the telephone
screening, but a more comprehensive description was obtained
when they completed the Rome II integrative questionnaire at the
time of the personal interview (20). Women with IBS symptoms
were eligible to participate if they met the Rome II criteria for
IBS and were diagnosed by a gastroenterologist within a year
prior to the study. In the event that a potential participant had
not been diagnosed within the past year, she was interviewed
by a gastroenterologist to establish a diagnosis of IBS. Women
who had hypertension, neurological disorders, cardiovascular
disorders, sleep disorders, fibromyalgia or who were night-shift
workers or currently pregnant were excluded from participation.
Healthy controls were excluded for the presence of gastroin-
testinal symptoms (>3 times per week) during the last 2 weeks
and significant depressive symptoms (BDI ≥12) (21). Reliabil-
ity and validity studies have determined that a cutoff score of
12 to 13 recognizes clinically significant depression (22). An-
tidepressant medication taken within the past 90 days was ex-
clusionary. Menopausal status was not considered exclusionary
and phase of menstrual cycle was not controlled. The study pro-
tocol was approved by the Institutional Review Board of the
University of Oklahoma Health Sciences Center and informed
consent was obtained from each participant during the personal
interview.
Procedures and Experimental Protocol
The participants were stratified into two groups based on
their self-reported depressive symptoms, measured by the Beck
Depression Inventory II (BDI-II). Women with substantial de-
pressive symptoms, defined as scoring 12 or higher on the
BDI-II (IBS+DS), were compared to a group of women
without depressive symptoms, scoring lower than 12 on the
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BDI-II (IBS−DS) and healthy controls. The BDI-II was com-
pleted during the personal interview, in conjunction with sev-
eral other questionnaires: a medical history and demographic
questionnaire, the Pittsburg Sleep Quality Index (PSQI), the
Spielberger State Anxiety questionnaire, and an 18-item gas-
trointestinal symptom questionnaire to determine gastroin-
testinal symptom severity and frequency (10, 23, 24). Each
participant completed the 90-item Symptom Checklist Re-
vised (SCL-90-R) the night of their polysomnographic (PSG)
sleep study (25). Following the personal interview, the partic-
ipants were scheduled for their polysomnography (PSG) sleep
study.
All participants underwent one overnight PSG sleep study.
Participants arrived at the laboratory on the day scheduled for
their PSG study at approximately 8:30 PM. They refrained from
medications (e.g., H2 blockers, medications causing drowsiness)
for a minimum of 48 hr prior to the PSG recording. They also
abstained from caffeine for at least 6 hr and nicotine for at
least 1 hr before reporting to the laboratory. They were in-
structed to consume their dinner prior to 6:00 PM and to re-
frain from any food and any beverages other than water after
6:00 PM.
Measures and Data Acquisition
Subjective Sleep Quality. The PSQI assessed subjective
sleep quality of the past 4 weeks and was administered dur-
ing the personal interview. The PSQI was scored according to
the guidelines provided by the authors (23). The PSQI instru-
ment produces a global score and seven subscale dimensions
(subjective sleep quality, latency, disturbances, efficiency, dura-
tion, sleeping medication, daytime disturbance). A higher score
indicates more sleep complaints.
Sleep Architecture. A standard PSG recording was com-
pleted including the EEG (central channels C3 and C4, occipital
channels O1 and O2, and references A1, A2, and CZ), elec-
trooculogram (EOG) (outer canther of each eye), and submental
electromyogram (EMG). In order to detect any respiratory dis-
order, an air pressure transducer with cannula was utilized, as
well as pulse oximetry and chest and abdominal effort record-
ings. The PSG recordings utilized digital Grass amplifiers and
the EEG signals were sent to a computer system with Grass
software for visual sleep stage determination. PSG recordings
were blindly scored according to internationally accepted sleep
staging criteria (26).
Autonomic Measures. Autonomic activity was determined
by heart rate variability (HRV) spectral analysis of the beat-to-
beat cardiac intervals (27, 28). HRV data were derived from the
ECG signal utilizing standard silver/silver chloride cutaneous
electrodes which were applied to the lower left side of the thorax
on the midaxillary line and on the right and left shoulder over
the clavicle to detect the ECG signal. A single channel of ECG
was recorded at a sampling rate of 6000 Hz and 16-bit resolution
and analyzed after being downsampled to 500 Hz. The internal
clock of the computer recording the ECG signal was synchro-
nized with the computer recording the PSG in order to allow
epoch-by-epoch matching of ECG with sleep stages and events.
The R–R intervals were calculated, resampled, and interpolated
by computer software, yielding the HRV signal for 15-min pe-
riods of a presleep waking period and stage 2, slow-wave, and
REM sleep. The 15-min segments were analyzed using the digital
signal processing toolbox of MATLAB to compute fast Fourier
transforms (Math Works Inc., Natick, MA) (29).
Autonomic functioning was assessed by the power of specific
frequency bands in the spectral analysis of HRV (30). The percent
high-frequency (HF) power band was a marker of vagal tone
defined as the percent power in the 0.15- to 0.50-Hz frequency
range. The percent low-frequency (LF) band power was defined
as 0.04–0.15 Hz and can include both vagal and sympathetic
influences, thus sympathetic activation is often inferred from the
LF/HF ratio (31). The LF/HF ratio was considered an indicator
of sympathovagal balance (14, 28). Each segment was analyzed
by spectral analysis to calculate the percentage LF band power,
percent HF band power, and LF/HF ratio.
Statistical Analyses
Multivariate analysis of variance (MANOVA) was con-
ducted to detect group differences for quantitative data. Two-
tailed independent t-tests determined mean differences for IBS
groups (IBS+DS, IBS−DS). Frequency data were analyzed by
Pearson’s chi-square analysis. Alpha level was set at 0.05 for
all statistical analyses. The Bonferroni correction was utilized to
adjust alpha for multiple comparisons.
RESULTS
All results are shown as mean ± standard error of the
mean (SE). Age and body mass index were used as co-
variates in the HRV analyses.
Demographic Characteristics
The IBS+DS group had a significantly higher body
mass index (BMI) and were older (Table 1) than the
IBS−DS group and healthy controls. The BDI-II means
for the IBS−DS and IBS+DS groups were statistically
significantly different, 4.9 and 20.2, respectively. The fre-
quency distribution is illustrated in Figure 1. Sixty-three
(69%) women were premenopausal and 28 (31%) women
were postmenopausal, but the difference was not statis-
tically significant. A total of 15 women were taking hor-
mone replacement therapy and the distribution was not sig-
nificantly different by group, nor was phase of menstrual
cycle different by group for the premenopausal women.
Subjective Sleep Quality
The overall MANOVA for subjective sleep qual-
ity detected significant group differences on the PSQI
(F[14,160] = 5.79, p < 0.01). Individual ANOVAs for
each PSQI dimension also revealed significant (P < 0.01)
group differences on each subscale, with IBS+DS reveal-
ing more dysfunction in every dimension (see Figure 2).
Multiple comparisons revealed that the IBS+DS group
had significantly (P < 0.05) higher global PSQI scores
(11.5 ± 0.5) than the IBS−DS group (8.0 ± 0.7) and
healthy controls (3.1 ± 0.3). The IBS−DS group also
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TABLE 1. PARTICIPANT CHARACTERISTICS
IBS−DS IBS+DS Healthy controls
(n = 44) (n = 26) (n = 21) P value
Age, years* 33.0 ± 1.1 40.1 ± 2.6† 34.7 ± 1.9 0.01
Race (n)
African American 3 2 0
Caucasian 39 20 19
Native American 1 2 1 NS
Hispanic 0 1 1
Asian 1 1 0
Body mass index, kg/m2* 25.0 ± 0.9 28.9 ± 1.2† 24.2 ± 0.7 0.01
Postmenopausal (n) 9 12 7 NS
Postmenopausal, taking hormone replacement therapy (n) 5 6 4 NS
Premenopausal, taking oral contraceptives (n) 14 3 5 NS
Follicular phase (n) 9 15 7
Ovulation phase (n) 15 2 5 NS
Luteal phase (n) 9 3 2
Note. Some of the columns do not sum to the total number of cases because of missing data. NS, nonsignificant.
*Data are mean ± SE.
†IBS+DS significantly (P < 0.05) greater than IBS−DS and controls.
had significantly (P = 0.01) higher PSQI scores than the
healthy controls.
Sleep Macroarchitecture
No respiratory disturbances were found in any of
the participants. The IBS+DS group took significantly
(P = 0.04) longer to enter their first REM period than
the healthy controls (see Table 2). There was a trend
(P = 0.08) for prolonged REM latency in the IBS−DS
group compared to healthy controls. No other group dif-
ferences in sleep macroarchitecture were found.
Fig 1. Beck Depression Inventory II Frequency Distribution. The IBS − DS group had significantly
lower BDI−II scores (4.9) than the IBS+ group (20.2).
Psychological Measures
A one-way ANOVA indicated that the IBS+DS group
had significantly (F[2,74] = 8.21, P < 0.01) higher
state anxiety than both the IBS−DS group (P <
0.01) and the healthy controls (P < 0.01). The in-
creased anxiety in the IBS+DS group was not sig-
nificantly correlated (r = 0.03, P = 0.88) with their
prolonged REM sleep latency. A MANOVA deter-
mined that the IBS+DS group scored significantly (P <
0.05) higher than the IBS−DS group and healthy con-
trols on the SCL-90-R global scores for psychological
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Fig 2. Subjective sleep quality, PSQI global score. The IBS+DS group reported significantly
(*P < 0.01) more sleep complaints on each of the PSQI subscales (global scores not shown)
than the IBS-DS group or controls. Bonferroni alpha adjustments were made. The data are mean
and SE.
disturbance as well as all of the subscales (see
Figure 3).
Autonomic Activity–Heart Rate Variability
Two individuals were eliminated from the analy-
sis due to artifacts (e.g., movement) occurring in the
15-min REM segment. A MANOVA was conducted to
determine group differences during each 15-min segment
(baseline presleep period and stage 2, slow-wave, and
REM sleep) for the LF/HF ratio during REM sleep. The
overall F-test (F[4,77] = 1.05, P = 0.38) did not in-
dicate any significant group differences (see Figure 4).
Two separate MANOVAs were conducted to detect any
group differences in percent LF band power and percent
TABLE 2. POLYSOMNOGRAPHIC PARAMETERS
IBS−DS IBS+DS Healthy controls
(n = 44) (n = 26) (n = 21) P value
Total sleep time (TST) (min) 378.9 ± 7.7 374.0 ± 11.0 378.7 ± 8.9 NS
Time in bed (TIB) (min) 442.5 ± 5.2 446.3 ± 7.3 439.8 ± 5.7 NS
Sleep onset latency (min) 23.9 ± 2.9 30.2 ± 6.3 22.7 ± 3.5 NS
Sleep efficiency (TST/TIB) 85.6 ± 1.5 83.7 ± 2.0 86.1 ± 1.6 NS
Number of awakenings after sleep onset 7.7 ± 0.7 8.6 ± 1.1 9.1 ± 1.2 NS
Stage 2 (%) 56.6 ± 1.3 58.2 ± 1.7 56.8 ± 1.6 NS
Stages 3 & 4 (slow-wave sleep; %) 17.2 ± 1.1 17.3 ± 1.6 16.3 ± 1.4 NS
REM sleep (%) 21.7 ± 0.9 21.6 ± 0.9 22.3 ± 0.9 NS
REM onset latency (min) 122.5 ± 10.5 126.3 ± 12.9* 84.9 ± 9.4 0.04
REM episodes 3.7 ± 0.2 3.8 ± 0.3 3.8 ± 0.2 NS
Note. Data are mean ± SE. NS, nonsignificant; REM, rapid eye movement.
*IBS+DS significantly (P < 0.05) greater than controls after Bonferroni alpha adjustment.
HF band power and there were no significant group dif-
ferences (F[4,66] = 1.7, P = 0.15, and F[4,66] = 1.8,
P = 0.16, respectively).
Gastrointestinal Symptom Profile
Nineteen of the IBS patients were constipation-
predominant, 31 IBS patients were diarrhea-predominant,
and 20 patients alternated between constipation and di-
arrhea symptoms. A Pearson’s chi-square did not de-
tect unequal distributions between the groups (Table 3).
All participants had similar reports of lower abdominal
pain approximately 4 days a week. The groups reported
having had their IBS symptoms for similar durations. As
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Fig 3. Psychological disturbance subscales (SCL-90-R). The IBS+DS
group had significantly (*P < 0.01) higher scores on each dimension
of the SCL-90-R than the IBS-DS group and controls. Bonferroni alpha
adjustments were made. The data are shown as mean and SE.
illustrated in Table 3, a majority (not statistically sig-
nificant) of participants (96 vs. 68%) in the IBS+DS
group reported that their abdominal pain prevented them
from sleeping. Analysis of the 18-item gastrointesti-
nal questionnaire revealed that the IBS+DS group re-
ported significantly (t = 2.08, df = 68, P = 0.01) more
gastrointestinal symptom severity than the IBS−DS
group.
DISCUSSION
The present data extend our previous work on the nature
of sleep complaints in women with IBS, which demon-
strated that women with IBS rated their sleep quality sig-
nificantly worse than healthy controls (9, 10). Previously,
we could not determine how much depressive symptoms
Fig 4. Autonomic activity across sleep stages. There were no significant
group differences in sympathetic dominance during sleep stages. The
raw data, without age and BMI adjustments, are shown as mean and SE.
affected subjective sleep complaints in IBS since depres-
sive symptoms were exclusionary. Sleep complaints are
common in depression, thus we hypothesized that depres-
sive symptoms in IBS would be associated with greater
sleep complaints. Indeed, the present data convincingly
confirm that sleep complaints in IBS are dramatically
affected by the presence of depressive symptoms. The
women with IBS and depressive symptoms had signif-
icantly greater sleep complaints than the women with
IBS without depressive symptoms as well as the healthy
controls.
Women with IBS and depressive symptoms reported
significantly more state anxiety than women with IBS
without depressive symptoms. To decipher the relation-
ship between anxiety and depression on subjective sleep
measures, we conducted an ANOVA utilizing anxiety as
a covariate. Results showed that subjective sleep com-
plaints remained significantly greater in the IBS group
with depressive symptoms compared to the IBS group
without depressive symptoms. This suggests that de-
pressive symptoms are important determinants of in-
creased sleep complaints in women with IBS and are
not modulated by the presence or absence of anxiety
symptoms.
Subjective sleep complaints in women with IBS were
not substantiated by objective alterations in sleep architec-
ture (e.g., efficiency, number of awakenings, or percent-
age of slow-wave sleep) in two of our earlier investiga-
tions (9, 10, 13, 14). The significantly longer REM latency
in IBS patients with depressive symptoms, compared to
IBS patients without depressive symptoms and controls,
had not been found in any of our previous investigations.
However, our previous studies excluded individuals with
depression. There have been two other studies that did
not exclude depressive symptoms in IBS and found pro-
longed REM latency compared to controls (12, 32). This
suggests that increased REM latency may be attributable
to the concurrent presence of depressive symptoms in IBS.
The presence of anxiety was not significantly correlated
with REM latency for any group.
The results from the objective sleep data may have been
affected by a first-night effect since participants slept in
the laboratory for 1 instead of 2 nights. The reasons for
this relate not only to issues of cost and feasibility but also
to the fact that previous studies have shown only minor
differences between consecutive sleep studies (33). An
important factor in minimizing the first-night effect is to
facilitate the participants comfort in the sleep laboratory
(34). To maximize their comfort, each participant had her
own private bedroom with all of the necessary furnishings
(extra pillows and blankets, fan, mirror, dresser vanity,
full-size mattress). In addition, there was a call button to
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TABLE 3. IBS SYMPTOM PROFILE
IBS−DS IBS+DS
(n = 44) (n = 26) P value
Predominant symptom
Constipation 23 8 NS
Diarrhea 9 10
Alternating 12 8
Days with pain/week 4.2 ± 0.3 3.8 ± 0.3 NS
>5 years suffered with pain, % 51 57 NS
Abdominal bloating, % 90 96 NS
Abdominal bloating/week 3.9 ± 0.3 3.6 ± 1 NS
Abdominal pain prevents falling asleep, % yes 68 96 NS
Abdominal pain awakens from sleep, % yes 78 96 NS
Gastrointestinal symptom severity 1.4 ± 0.1 1.7 ± 0.1* 0.04
Excessive passing of gas by rectum 0.93 ± 0.2 1.6 ± 0.2* 0.01
Overly full or bloated 1.3 ± 0.2 2.1 ± 0.2* 0.01
Incomplete bowel movement >25% of the time 1.4 ± 0.2 2.2 ± 0.2* 0.01
Nausea 0.9 ± 0.1 1.4 ± 0.2* 0.03
Strain >25% of the time during a bowel movement 1.6 ± 0.1 2.1 ± 0.2* 0.05
Note. Some of the columns do not sum to the total number of cases of missing data. NS, nonsignificant.
*Range: 0 (never occurs) to 3 (occurs more than 2 times per week).
alert the sleep technician for any additional requests (i.e.,
restroom break, adjust temperature in the room). We feel
it is unlikely that a “first-night effect” would appreciably
alter our results.
Our previous work on sympathovagal balance across
sleep stages demonstrated that compared to non-REM
sleep, REM sleep is associated with an increase in sym-
pathetic dominance, measured by the LF/HF ratio, in IBS
patients compared to healthy controls (13, 14). The re-
sults of this study do not support any relationship between
depressive symptoms and autonomic activity in women
with IBS. A study similar to ours was conducted by Jarrett
et al., investigating the impact of depression in IBS on au-
tonomic functioning across 24-hr recordings (18). They
reported lower vagal tone averaged across 24 hr in women
with IBS who had clinically diagnosed depression com-
pared to women with IBS who were not diagnosed with
depression. However, our inability to detect group differ-
ences for sympathovagal balance (LF/HF) is consistent
with the findings of Jarrett et al. despite the methodologi-
cal differences between the two studies. First, this investi-
gation focused on the presence of depressive symptoms in
IBS rather than a clinical diagnosis of depression. Second,
we specifically assessed autonomic activity across sleep
stages rather than averaging across a 24-hr time period
or averaging across the total sleep period (18, 35). To re-
iterate, this was the first study to investigate autonomic
changes during specific sleep stages in women with IBS
who have depressive symptoms. Although these findings
are not consistent with the existing literature of increased
sympathetic dominance in depressed patients, daytime or
averaged 24-hr recordings were utilized rather than eval-
uating specific sleep stages verified by polysomnographic
recordings (16, 17).
A further explanation of our findings relates to the
fact that the majority of studies investigating depres-
sion and autonomic activity either have been conducted
in males or have failed to control for gender differ-
ences (16–18, 36). There are data to show that males
and females differ in HRV parameters (37). For exam-
ple, Bonnemeier et al. detected shorter R–R intervals
(msec) across 24-hr recordings in females compared to
males and Elsenbruch et al. found increased sympa-
thetic dominance during REM sleep in males compared
to females (38, 39) Hence, previous reports of increased
sympathetic dominance in depression using HRV may
be confounded by gender differences. Clearly, the in-
terpretation of our present findings is hampered due to
the lack of data on cardiac autonomic activity in males
and females with clinically diagnosed major depressive
disorder.
In summary, the present study represents the largest
sample of IBS patients with full PSG reported to date
(n = 70). The outcome of this study indicates that de-
pressive symptoms in IBS affect sleep macroarchitecture
and subjective sleep, but the depressive symptoms are
not specifically associated with autonomic changes during
sleep. Thus, these data provide substantial documentation
of the importance of comorbid depression in the mani-
festation of both daytime and nighttime gastrointestinal
symptoms as well as subjective and objective sleep in pa-
tients with IBS.
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